title: Endolymphatic hydrops associated with otosclerosis.
abstract: Endolymphatic hydrops (EH) associated with otosclerosis has been noted for many years. However, the causal relationship of these two entities remains controversial. Having reviewed the records of patients with otosclerosis describing fluctuant hearing loss and vertiginous symptoms, the authors found the EH may coexist with otosclerosis preoperatively; they may be two separate diseases that exist coincidentally; or EH may be caused by the otosclerotic process. Secondly, EH may occur with a fistula after surgery. Occurring after stapedectomy, EH may be caused by fistulization of the bony labyrinth, which is effectively treated by surgery to seal the fistula, which may cause EH to subside and hearing to improve. Thirdly, delayed EH may occur months or years after stapedectomy, possibly as a result of otosclerotic foci or surgical insult to the labyrinth. Dexamethasone, diuretics, and a room air rebreather can be used in the treatment of delayed EH. Hearing may be maintained or may deteriorate, but there usually is no dizziness. The clinical manifestations of EH associated with otosclerosis include a conductive or mixed type of hearing loss; the presence of fullness, tinnitus, fluctuation of hearing, episodic vertigo, an elevated negative summating potential (SP), and an increased summating potential:action potential (SP:AP) ratio shown by ECoG. This report presents five cases of EH associated with otosclerosis.
authors.affiliation: Shea Clinic, Shea Clinic Foundation, Memphis, TN 38119, USA.
authors.forename: J J
authors.initials: JJ
authors.lastname: Shea
authors.forename: X
authors.initials: X
authors.lastname: Ge
authors.forename: D J
authors.initials: DJ
authors.lastname: Orchik
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001299:Audiometry; D001300:Audiometry, Evoked Response; D015897:Comorbidity; D003907:Dexamethasone / Q000627:therapeutic use; D007758:Ear, Inner / Q000503:physiopathology; D018159:Endolymphatic Hydrops / Q000188:drug therapy / Q000453:epidemiology* / Q000503:physiopathology; D005260:Female; D006314:Hearing Loss, Conductive / Q000175:diagnosis / Q000453:epidemiology; D006801:Humans; D008297:Male; D008575:Meniere Disease / Q000453:epidemiology; D008875:Middle Aged; D010040:Otosclerosis / Q000453:epidemiology* / Q000503:physiopathology / Q000601:surgery; D013201:Stapes Surgery / Q000009:adverse effects
chemical_list: D000893:Anti-Inflammatory Agents; D003907:Dexamethasone